Clinical trials
Phase 2 Lymphoma, Follicular trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 5 |
| 2008 | 2 |
| 2009 | 3 |
| 2011 | 3 |
| 2012 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 42 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Auxilio Mutuo Cancer Center | 2 |
| Clinica Universidad de Navarra, Universidad de Navarra | 2 |
| French Innovative Leukemia Organisation | 2 |
| Herbert Irving Comprehensive Cancer Center | 2 |
| Ruijin Hospital | 2 |
| Shanghai YingLi Pharmaceutical Co. Ltd. | 2 |
| Theradex | 2 |
| Amgen | 1 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 1 |
| Charite University, Berlin, Germany | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Follicular | 42 |
| Lymphoma | 18 |
| Lymphoma, Non-Hodgkin | 17 |
| Lymphoma, Large B-Cell, Diffuse | 16 |
| Burkitt Lymphoma | 13 |
| Lymphoma, B-Cell, Marginal Zone | 13 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 12 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 11 |
| Lymphoma, Large-Cell, Immunoblastic | 11 |
| Lymphoma, Mantle-Cell | 11 |
Trials
Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.